BLAINJECTIONINJECTABLEPriority Review
Approved
Apr 2014
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
12
Mechanism of Action
Interleukin-6 Antagonists
Pharmacologic Class:
Interleukin-6 Antagonist
Clinical Trials (5)
Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
Started Jan 2025
20 enrolled
Non-Hodgkin LymphomaCytokine Release Syndrome
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Started Nov 2024
215 enrolled
Multiple Myeloma
Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease
Started Mar 2021
22 enrolled
Idiopathic Multicentric Castleman's Disease
SILtuximab in Viral ARds (SILVAR) Study
Started Nov 2020
555 enrolled
Acute Respiratory Distress SyndromeLung DiseasesPneumonia+2 more
Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer
Started Jan 2020
35 enrolled
Metastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8